ISABS: Personalized Medicine Conference With Nobel Laureates t... - 16 February 2019 00:04

ZAGREB, Croatia and WASHINGTON, Feb. 15, 2019 /PRNewswire-AsiaNet/-- International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" (http://www.isa...

  Beijing Intellectual Property Court Confirms Judgment Against ... - 14 February 2019 22:59

PARIS, Feb. 14, 2019 /PRNewswire-AsiaNet/ -- Echosens, an innovative high-technology company offering the FibroScan family of products dedicated to assessment of chronic liver disease, today announces that the Beijing Intellectual Property Court has confirmed judgment against Wuxi Hisky...

  SK Biopharmaceuticals and Arvelle Therapeutics Announce Agreem... - 14 February 2019 19:00

GYEONGGI, South Korea, Feb. 14, 2019 /PRNewswire-AsiaNet/ -- -- Arvelle Therapeutics to receive rights to develop and commercialize cenobamate, an investigational antiepileptic drug developed by SK Biopharmaceuticals, in Europe -- SK Biopharmaceuticals to receive upfront payment of $100 million and will ...

  Jubilant Biosys Expands Collaboration With Sanofi in CNS Thera... - 13 February 2019 19:05

BANGALORE, India, Feb. 13, 2019 /PRNewswire-AsiaNet/-- Collaboration aimed at discovery of small molecule inhibitors targeting neurological disorders Jubilant Biosys, a Bengaluru-based subsidiary of Jubilant Life Sciences, today announced a new integrated drug discovery collaboration w...

  Texas Cardiac Arrhythmia Institute at St. David's Medical Cent... - 13 February 2019 10:08

AUSTIN, Texas, Feb. 13, 2019 /PRNewswire-AsiaNet/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently performed the first procedure in the U.S. using the new HELIOSTAR Multi-electrode Radiofrequency (RF) Balloon Ablation Catheter as part of the STELLAR study. The ...

  FDA Accepts sBLA and Grants Priority Review for BAVENCIO(R) (a... - 12 February 2019 10:26

DARMSTADT, Germany and NEW YORK, Feb. 11, 2019 /PRNewswire-AsiaNet/ -- Not intended for US, Canada and UK-based media Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for ...

  Preliminary Study Finds Healbe GoBe2 Offers Accuracy in Measur... - 11 February 2019 21:24

REDWOOD CITY, California, February 11, 2019 /PRNewswire-AsiaNet/ -- A preliminary study of a health monitoring smartband, the Healbe GoBe2, showed the technology to be about 89 percent accurate in automatic tracking of digested calories. A 14-day study was completed by 27 adult volunteers between the ages 18-4...

  OneTouch(R) Blood Glucose Monitoring System Accuracy Proven in... - 08 February 2019 08:00

CHESTERBROOK, Pennsylvania, Feb 8, 2019 /PRNewswire-AsiaNet/-- --Research demonstrates clinical accuracy of OneTouch Select Plus(R) platform, and demonstrates the value of a continuous and systematic testing program to verify product performance for as long as it has been available to patients New researc...

  BioLineRx Announces Closing of $15.4 Million Underwritten Publ... - 08 February 2019 04:57

TEL AVIV, Israel, Feb. 8, 2019 /PRNewswire-AsiaNet/ -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced that it has closed its previously announced underwritten public offering of 28,000,000 American Depositary Shares ("...

  Merck to Expand US Biopharmaceutical R&D Facility to Advance I... - 07 February 2019 01:05

DARMSTADT, Germany, February 7, 2019 /PRNewswire-AsiaNet/ -- Not intended for US, Canada or UK-based media Merck to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline - Merck investing $70 million in U.S. Research & Development Hub - Expansion of R&D footprint to ac...